Francesco Passamonti

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (9)

Tarec Christoffer El‐Galaly

DENMARK

View details

Valerio De Stefano

ITALY

View details

Jan Novak

CZECH REPUBLIC

View details

antonio pagliuca

King's College London

UNITED KINGDOM

View details

Luca Arcaini

ITALY

View details

Alessandro Rambaldi

University of Milan

ITALY

View details

B. Deau

FRANCE

View details

Adam Mead

University of Oxford

UNITED KINGDOM

View details

Isabel Regalado-Artamendi

Instituto de Investigación Sanitaria Gregorio Marañón

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francesco Passamonti

Research Interests

Explore related searches

Contact this professor

Articles (11)

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach

Androgen use in bone marrow failures and myeloid neoplasms: Mechanisms of action and a systematic review of clinical data

Early treatment for COVID‐19 in patients with haematological malignancies: Much more than a recommendation!

Deciphering molecular complexity of HCV‐associated lymphoproliferation

Management of patients with lymphoma and COVID‐19: Narrative review and evidence‐based practical recommendations

Acquired Thrombotic Thrombocytopenic Purpura After ChAdOx1 nCoV-19 Vaccine: A Case Report

Myelofibrosis

The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies

Collaborators (9)

Tarec Christoffer El‐Galaly

Valerio De Stefano

Jan Novak

antonio pagliuca

Luca Arcaini

Alessandro Rambaldi

B. Deau

Adam Mead

Isabel Regalado-Artamendi

Make your next move.